The Marcus Corporation Announces Second Quarter Fiscal 2021 Release Date and Conference Call

MILWAUKEE--(BUSINESS WIRE)-- The Marcus Corporation (NYSE: MCS) today announced it will report results for the second quarter of fiscal 2021 prior to the stock market open on Wednesday, August 4, 2021. The release will be followed by a conference call at 10:00 a.m. Central/11:00 a.m. Eastern time.

Participants may listen to the call live on the internet through the investor relations section of the company's website: www.marcuscorp.com, or by dialing 1-574-990-3059 and entering the passcode 2768307. Listeners should dial in to the call at least 5-10 minutes prior to the start of the call or should go to the website at least 15 minutes prior to the call to download and install any necessary audio software.

A telephone replay of the conference call will be available through Wednesday, August 11, 2021, by dialing 1-855-859-2056 and entering passcode 2768307. The webcast will be archived on the company’s website until its next earnings release.

About The Marcus Corporation

Headquartered in Milwaukee, The Marcus Corporation is a leader in the lodging and entertainment industries, with significant company-owned real estate assets. The Marcus Corporation’s theatre division, Marcus Theatres®, is the fourth largest theatre circuit in the U.S. and currently owns or operates 1,091 screens at 88 locations in 17 states under the Marcus Theatres, Movie Tavern® by Marcus and BistroPlex® brands. The company’s lodging division, Marcus® Hotels & Resorts, owns and/or manages 18 hotels, resorts and other properties in eight states. For more information, please visit the company’s website at www.marcuscorp.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210721005215/en/

Douglas A. Neis
(414) 905-1100

Source: The Marcus Corporation

You May Also Be Interested In

• Bristol-Myers Squibb (BMY) stock slips despite earnings beat
• EMCOR Group, Inc. Reports First Quarter 2024 Results
• Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study